La jolla Pharmaceutical
About:
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
Website: https://www.lajollapharmaceutical.com
Description:
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics for chronic organ failure and cancer. GCS-100, the Company's lead product candidate, is a first-in-class inhibitor of galectin-3, a novel molecular target implicated in chronic organ failure and cancer. LJPC-501, the Company's second product candidate, is a natural peptide for the treatment of the hepatorenal syndrome.
$191M
$50M to $100M
San Diego, California, United States
1989-01-01
medicalinformation(AT)ljpc.com
101-250
2015-09-09
Public
© 2025 bioDAO.ai